BR9906833A - Processes and compositions to treat diagnosing insulin-related disorders - Google Patents

Processes and compositions to treat diagnosing insulin-related disorders

Info

Publication number
BR9906833A
BR9906833A BR9906833-8A BR9906833A BR9906833A BR 9906833 A BR9906833 A BR 9906833A BR 9906833 A BR9906833 A BR 9906833A BR 9906833 A BR9906833 A BR 9906833A
Authority
BR
Brazil
Prior art keywords
processes
treat
compositions
insulin
related disorders
Prior art date
Application number
BR9906833-8A
Other languages
Portuguese (pt)
Inventor
William Clifford Duckworth
Frederick G Hamel
Original Assignee
William Clifford Duckworth
Frederick G Hamel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Clifford Duckworth, Frederick G Hamel filed Critical William Clifford Duckworth
Publication of BR9906833A publication Critical patent/BR9906833A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PROCESSOS E COMPOSIçõES PARA TRATAR EDIAGNOSTICAR DISTúRBIOS RELACIONADOS à INSULINA".A presente invenção refere-se aos processos e composições paratratar ou reduzir sintomas de distúrbios de deficiência absoluta ourelativa à insulina, resistência severa à insulina, de acúmulo ouexcesso de síntese de lipídeos, ou de catabolismo ou degradaçãode proteína. A invenção também inclui processos para detectar eavaliar tratamentos de tais distúrbios."PROCESSES AND COMPOSITIONS TO TREAT EDIAGNOSTICATE INSULIN-RELATED DISORDERS" .The present invention relates to processes and compositions to treat or reduce symptoms of absolute insulin deficiency disorders, severe resistance to insulin, accumulation or excess lipid synthesis, or catabolism or protein degradation. The invention also includes processes for detecting and evaluating treatments for such disorders.

BR9906833-8A 1998-01-08 1999-01-08 Processes and compositions to treat diagnosing insulin-related disorders BR9906833A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7082198P 1998-01-08 1998-01-08
PCT/US1999/000471 WO1999035169A2 (en) 1998-01-08 1999-01-08 Methods and compositions for treating and diagnosing insulin related disorders

Publications (1)

Publication Number Publication Date
BR9906833A true BR9906833A (en) 2001-11-27

Family

ID=22097585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9906833-8A BR9906833A (en) 1998-01-08 1999-01-08 Processes and compositions to treat diagnosing insulin-related disorders

Country Status (7)

Country Link
EP (1) EP1045860A2 (en)
JP (1) JP2002500234A (en)
CN (1) CN1292798A (en)
AU (1) AU2313899A (en)
BR (1) BR9906833A (en)
CA (1) CA2317674A1 (en)
WO (1) WO1999035169A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465714B2 (en) * 1999-11-05 2002-10-15 Arexis Ab Congenic animal models of non-insulin dependent diabetes mellitus
WO2006132530A2 (en) * 2005-01-31 2006-12-14 Leiden University Medical Center Methods and means for use in diagnostics and treatment of diabetes
JP2012507021A (en) * 2008-10-31 2012-03-22 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング Methods and assays for classifying foods and / or beverages and / or diets and / or nutrition plans and / or drugs for effects on the cardiovascular system
EP2391377A2 (en) * 2009-02-02 2011-12-07 Ramot at Tel-Aviv University Ltd. Peptides, pharmaceutical compositions comprising same and uses thereof
WO2012017439A2 (en) 2010-08-04 2012-02-09 Ramot At Tel-Aviv University Ltd. Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
CN104961706B (en) * 2015-07-06 2017-03-01 成都知普莱生物医药科技有限公司 A kind of method of insulin synthesis degraded enzyme inhibitor ML345
CN115477686B (en) * 2022-09-22 2024-01-30 北海黑珍珠海洋生物科技有限公司 Pearl shell active peptide with whitening effect and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891435A (en) * 1993-04-16 1999-04-06 Research Corporation Technologies, Inc. Methods and compositions for delaying or preventing the onset of autoimmune disease
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US5594100A (en) * 1995-02-22 1997-01-14 Regents Of The University Of Colorado Epitope for prevention of type I diabetes

Also Published As

Publication number Publication date
CA2317674A1 (en) 1999-07-15
WO1999035169A9 (en) 1999-11-11
JP2002500234A (en) 2002-01-08
AU2313899A (en) 1999-07-26
CN1292798A (en) 2001-04-25
WO1999035169A3 (en) 1999-10-07
EP1045860A2 (en) 2000-10-25
WO1999035169A2 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
Attiullah et al. Clinical features of obsessive-compulsive disorder
BR0209812A (en) Use of osteopontin for the treatment and / or prevention of neurological diseases.
BR9709915A (en) Compound pharmaceutical composition use of the compound and processes for the treatment or prevention of physiological disorders associated with an excess of tachykinins and for the preparation of the compound
ATE461941T1 (en) ANTIBODIES AGAINST ALZHEIMER'S SPECIFIC TAU PROTEINS WITH ABNORMAL CONFORMATION
BR9915744A (en) 3-substituted 4-arylquinolin-2-one derivatives as modulators of the potassium channel
BR0016385A (en) Compounds or combinations thereof which have seratonin reuptake inhibitory activity and a 5-ht2c antagonist, inverse agonist or partial agonist; use thereof; pharmaceutical composition and method
ES2162843T3 (en) INHIBITORS OF PROTEIN QUINASA C.
BR9713404A (en) esters of n- (aryl / heteroarylacetyl) amino acids, pharmaceutical compositions comprising them, and methods for inhibiting the release of beta-amyloid peptide and / or its synthesis by using such compounds.
BR9914066A (en) Human complement c3-degrading polypeptide from streptococcus pneumoniae
BR9906833A (en) Processes and compositions to treat diagnosing insulin-related disorders
BRPI0413556A (en) amyloid accumulating disease probes, amyloid dyeing agents, drugs for treatment and prophylaxis of accumulated amyloid diseases, and neurofibrillary tangle diagnostic probes and neurofibrillary tangle dyeing agents
MA30903B1 (en) 2-PHENYL-6-MINOCARBONYL-PYRIMIDINE DERIVATIVES
BR9603075A (en) Shoe sole with co-molded non-slip fitting
WO1997040072A3 (en) Adam proteins and uses thereof
WO2000034511A3 (en) Aβ-PEPTIDE SCREENING ASSAY
BRPI0408889A (en) Clusterin use for treatment and / or prevention of peripheral neurological diseases
BR0108802A (en) Diagnostic and therapeutic methods for glaucoma
DE60228878D1 (en) PROTEINS WITH IL-6 INHIBITORAL EFFECT
AU5596998A (en) Pyk2 related products and methods
ATE318328T1 (en) DIAGNOSTICS AND THERAPEUTIC PRODUCTS FOR OSTEOPOROSIS
BR9607613A (en) Rapid test for determining the amount of inactive functionality gene in a gene therapy vector preparation
EP1731913A3 (en) Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
PT1390531E (en) ANALYSIS OF HYPERTONIA'S QUANTITATIVE DIAGNOSIS
KR960000248A (en) Bone Metabolism Disorders
ATE312914T1 (en) RDGB PROTEINS

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.